PS
WST icon

Planned Solutions’s West Pharmaceutical WST Stock Holding History

Planned Solutions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-110
Closed -$33K – 643
2024
Q3 		$33K Buy
+110
New +$33.7K 0.01% 349
2024
Q1 		– Sell
-110
Closed -$38.7K – 562
2023
Q4 		$38.7K Buy
+110
New +$38.9K 0.02% 308

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Planned Solutions's WST Position: Q4 2024 in Review

Planned Solutions sold out of West Pharmaceutical (WST) in Q4 2024, closing a stake of 110 shares — an estimated $33K sold.

Planned Solutions first reported a position in WST in Q4 2023 and held it in 2 quarters. The position peaked at $38.7K in Q4 2023. 748 funds tracked by Wall St. Rank hold WST as of Q4 2024.

  • Planned Solutions reported no remaining West Pharmaceutical position as of Q4 2024 after selling out during the quarter.
  • Planned Solutions sold 110 West Pharmaceutical shares in Q4 2024, an estimated $33K.
  • Planned Solutions first reported a position in West Pharmaceutical in Q4 2023 and held it in 2 quarters.
  • Planned Solutions's West Pharmaceutical position peaked at $38.7K in Q4 2023.
  • 748 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2024.

Based on Planned Solutions's 13F filing for Q4 2024, filed 17 Jan 2025.